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The number of consumer products containing nanomaterials (NM) in the European 
market showed a 6-fold increase in 2010 (RIVM report, 2010), reflecting the growing 
relevance of nanotechnology and the broad field of applications of NM across 
consumer, medical and industrial products. Although the use of NM may offer 
enormous benefits, it may also pose risks to human health, especially to workers who 
may face higher exposure, and to environment.  Several studies have reported that the 
greater surface area per mass renders NM more reactive than larger-sized particles of 
similar chemistry. Size, surface properties, agglomeration state, biopersistence and dose 
are also likely to modify cell responses to NM, presenting a challenge to the assessment 
of their potential hazards to human health. Titanium dioxide (TiO2) and zinc oxide 
(ZnO) nanoparticles (NP) are frequently used in sunscreens and cosmetics. Although 
cytotoxic and genotoxic properties of TiO2-NP and ZnO-NP have been investigated, 
conflicting results have been reported.  Differences inherent to cell lines, NPs 
characterization, dispersion protocols, exposure times and assays, together with the lack 
of positive NM controls have lead to difficulties in the toxicity assessment of those NM. 
As a part of a larger project (www.nanogenotox.eu), aimed at establishing a robust 
methodology to evaluate the potential genotoxicity of manufactured NM, the objective 
of the present work was to characterize the potential genotoxic effects of TiO2-NP 
(anatase, hydrophilic rutile, hydrophobic rutile and rutile/anatase) in primary cultures of 
human lymphocytes. 
The cytokinesis-block micronucleus (CBMN) assay was carried out according to OECD 
guidelines. Dispersions of each NP were freshly prepared and cultures were exposed to 
NP concentrations (5-250 µg/mL), during 30h. Concurrent control cultures were 
processed: vehicle control, positive control (mytomicin C, MMC) and a reference NP 
(ZnO-NP).  
The results show that none of the four TiO2-NP tested induced a dose-related increase 
in MN frequency in lymphocytes. Likewise, the cytokinesis-block proliferation index 
(CBPI) was not significantly affected by TiO2-NP treatments, indicating no influence 
on cell cycle progression. As to the positive control, MMC induced a significant 
increase in the frequency of MN and a concomitant decrease in the CBPI, whereas ZnO-
NP caused a decrease in the CBPI without affecting the frequency of MN.  
In conclusion, the results suggest that the tested TiO2-NP are not clastogenic or 
aneugenic in human lymphocytes, under the selected test conditions. Further data using 
different cell types and other endpoints, together with the study of in vivo genotoxic and 
toxicokinetics parameters, are expected to clarify if these TiO2-NP can be considered as 
non-genotoxic to humans. 
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